Cellectis (CLLS) FCF Margin Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 10,029.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 723.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1,409.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 6,066.00 |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.00 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 167,346.00 |
| Mar 31, 2025 | 23,760.00 |
| Sep 30, 2024 | 27,937.00 |
| Jun 30, 2024 | 71,992.00 |
| Mar 31, 2024 | -46,699.00 |
| Dec 31, 2023 | 1.58 Mn |
| Sep 30, 2023 | -1.05 Mn |
| Jun 30, 2023 | -1.03 Mn |
| Mar 31, 2023 | -2.02 Mn |
| Sep 30, 2022 | -1.44 Mn |
| Jun 30, 2022 | -15,203.00 |
| Mar 31, 2022 | 159,212.00 |
| Sep 30, 2021 | 121,031.00 |
| Jun 30, 2021 | 17,781.00 |
| Mar 31, 2021 | 27,716.00 |
| Dec 31, 2020 | -57,882.00 |
| Sep 30, 2020 | -6,841.00 |
| Jun 30, 2020 | -3,191.00 |
| Mar 31, 2020 | 25,231.00 |
| Dec 31, 2019 | -38,966.00 |
| Sep 30, 2019 | -20,753.00 |
| Jun 30, 2019 | -39,231.00 |
| Mar 31, 2019 | -180,130.00 |
| Dec 31, 2018 | -294,338.00 |
| Sep 30, 2018 | -146,269.00 |
| Jun 30, 2018 | -2,230.00 |
| Mar 31, 2018 | -33,837.00 |